FLT3 and acute myeloid leukemia: Of note, therapeutic intervention with the glycolytic inhibitor 2‐deoxyglucose (2‐DG) has been reported to induce cell death and exert antiproliferative effects in FLT3‐ITD AML in vitro through a marked inhibition of aerobic glycolysis.